Tolvaptin
Ended Awarded Last action
- Contract number
- 36C26222N0071
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $144,045
Award facts
- Contract value 100% obligated
- $144,045.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $10,303 | |
| Supplemental Agreement for work within scope | $10,099 | |
| Original award | $123,643 |
About this award
On October 1, 2021, the Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 22, awarded a delivery order to Otsuka America Pharmaceutical Inc. for the supply of Tolvaptin with a ceiling value of $144,045.41. This firm fixed-price delivery order, which was completed on September 30, 2022, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and did not utilize any set-aside designations. The contract supports VISN 22's mission of providing specialized pharmaceutical treatments to veterans, with performance to be completed in Potomac, Maryland.
This delivery order is issued under Otsuka America Pharmaceutical Inc.'s larger Indefinite Delivery Vehicle with the VA, which includes an $83.3 million Blanket Purchase Agreement for Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. As a major pharmaceutical supplier to the Veterans Health Administration, Otsuka America maintains significant federal supply schedule contracts totaling approximately $396 million for pharmaceuticals and hematology products, enabling VA facilities across multiple Integrated Service Networks to efficiently procure critical medications for veterans nationwide.
Quick answers
Who was awarded contract 36C26222N0071?
36C26222N0071 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on October 1, 2021.
How much is contract 36C26222N0071 worth?
The government has obligated $144,045 on 36C26222N0071.
Is contract 36C26222N0071 an order under another contract?
Yes. 36C26222N0071 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26222N0071 competed?
The extent of competition for 36C26222N0071 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award